Psoriatic Arthritis Market Info™ 2011

Published by: Drug Market Info

Published: Aug. 1, 2011 - 84 Pages


Table of Contents

1. Patients: Understanding Psoriatic Arthritis (23 slides)
Description
Epidemiology
Disease Classification
Important PsA Clinical Features
Diagnosis
PsA Key Facts
Featured PsA Patient
Patient Insights
2. Perspectives: Psoriatic Arthritis Management (25 slides)
TPsA Treatment Goals
PsA Therapy Overview
Treatment Assessment Tools
Mild PsA: Therapeutic Profiles, Benefits/
Moderate/Severe PsA: DMARD Profiles, Benefits/Risks
Moderate/Severe PsA: Biologic Profiles, Benefits/Risks
Physicians Treating PsA
PsA Treatment Dynamics
Patient Insights on PsA Treatment
PsA Therapy: Key Issues
3. Potential: The Psoriatic Arthritis Market (19 slides)
PsA Market Definition
PsA Sales by Treatment Type
5-Year Sales Trends by Treatment Type
Sales versus Prescription Share by Treatment Type
5-Year Prescription Trends
Leading Product Sales and Companies
Most Frequently Used PsA Products
PsA Therapy Costs
Price to Patients
PsA Pipeline: Overview, Targets, Late Stage
PsA Patient Insights
Psoriatic Arthritis Summary (5 slides)
Why the PsA Market is Attractive
Six Most Important Facts about Psoriatic Arthritis
What Patients Want
National Psoriasis Foundation (NPF)
Clinician Reviewer
Appendix:
Acknowledgements
Market Value Calculation
Helpful Resources
About the Authors
Other Services
Bibliography
List of Tables
Psoriatic Arthritis Description
Psoriatic Arthritis Epidemiology
Psoriatic Arthritis Classification
Psoriatic Diagnosis & Severity
Psoriatic Arthritis Key Facts & Marketing Implications
Featured Psoriatic Arthritis Patient
Psoriatic Arthritis Treatment Goals
Psoriatic Arthritis Therapy Overview
Psoriatic Arthritis Treatment Assessment Tools
Mild Psoriatic Arthritis Therapeutic Profiles, Benefits/Risks
Moderate/Severe PsA Treatment: DMARD Profiles, Benefits/Risks
Moderate/Severe PsA Treatment: Biologic Profiles, Benefits/Risks
Psoriatic Arthritis Therapy: Key Issues
Psoriatic Arthritis Market Definition
Leading Sales Products for Psoriatic Arthritis
Leading Companies in Psoriatic Arthritis
Most Frequently Used Products for Psoriatic Arthritis
Cost of DMARDs (AWP)
Cost of Biologic Therapies (AWP)
PsA Pipeline Overview, Targets, Late Stage
The Six Most Important Facts about Psoriatic Arthritis
List of Charts
Psoriatic Arthritis U.S. Point Prevalence
Patient Reported Age at Diagnosis
Psoriatic Arthritis Effect on Daily Living
Psoriatic Arthritis Effect on Unemployment
Psoriatic Arthritis Treatment Goals
Psoriatic Arthritis Therapy Overview
Physicians Treating Psoriatic Arthritis
# of MD Visits/Year for Routine Care of Psoriasis
Prescription Medication Usage by Psoriatic Arthritis Patients
Psoriatic Arthritis Patient Satisfaction with Treatment
2010 Market Share of Sales by Treatment Modality
Five-Year Sales Trends by Treatment Modality
2010 Share Comparison: Sales and Prescriptions by Treatment Modality
Five-Year Prescription Trends by Treatment Modality
DMARDs: Sales & Prescription Trends
Biologics: Sales & Prescription Trends
Patient Price of DMARDs

Abstract

Get the complete review of Psoriatic Arthritis with full sections covering Patients, Perspectives and Potential. Everything you need to know about Psoriatic Arthritis, treatments and market value. Psoriatic Arthritis Market Info™ - 2011 is a discounted prior year report providing good value for clients not requiring the most current year of sales and prescription data.

Psoriatic Arthritis (PsA) is a form of arthritis that is often associated with psoriasis of the skin. Up to 30% of people with psoriasis also develop psoriatic arthritis, which causes pain, stiffness and swelling in and around the joints. Genetic predisposition, the immune system and environmental factors are all believed to play a role in the onset of Psoriatic Arthritis. Without treatment, this chronic, debilitating disease can be life-altering.

With the increased use of biologics, such as Enbrel® (Amgen/Pfizer), the Psoriatic Arthritis market has experienced strong growth over the past few years. In addition, the cost of these therapies has driven the market to the $1 billion+ level. Psoriatic Arthritis Market Info™ from Drug Market Info captures explicit data on this disorder, which is often hard to obtain. In many cases, PsA market information tends to be “lumped” or buried within data for rheumatoid arthritis or psoriasis. For this reason, Psoriatic Arthritis Market Info specifically focuses only on this condition.

It’s as easy as one, two, three with Psoriatic Arthritis Market Info. Insights on patients, doctors, treatment and market value are presented in an easy-to-follow format with reliable, referenced data.

Section One: Patients - Understanding Psoriatic Arthritis: Focuses on patients and how they feel about their disease. Includes basic disease information, as well as epidemiology.

Section Two: Perspectives - Psoriatic Arthritis Management: A review of therapies, advantages and disadvantages, listing of major products and companies. Includes patients’ perspectives, experiences and insights on various therapies.

Section Three: Potential - Psoriatic Arthritis Market: Overall sales and prescription volume, growth rates and key products and companies provided. Includes pipeline products and market attractiveness assessment.

Summary: The major take-aways from the presentation, including “What Makes the Psoriatic Arthritis Market Attractive,” “Six Most Important Facts About the PsA Market,” “Patient Insights” and a statement from the National Psoriasis Foundation (NPF).

Get full details about this report >>
 
Learn more about this product


Price and delivery options
Search Inside Report

US: 800.298.5699

Int'l: +1.240.747.3093

 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports, company profiles and country profiles from over 720 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.